{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:44:05Z","timestamp":1779335045702,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Research & Clinical Practice"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.orcp.2023.05.004","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T08:24:32Z","timestamp":1684484672000},"page":"210-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of biologic agents on body weight and obesity-related disorders in patients with psoriasis: A nationwide population-based cohort study"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2422-1970","authenticated-orcid":false,"given":"Hyunhee","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee-Young","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seunghyun","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee-Hyun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.orcp.2023.05.004_bib1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.5021\/ad.2017.29.6.761","article-title":"Prevalence of psoriasis in Korea: a population-based epidemiological study using the Korean National Health Insurance Database","volume":"29","author":"Lee","year":"2017","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.orcp.2023.05.004_bib2","first-page":"9","article-title":"Psoriasis: comorbidities and associations","volume":"146","author":"Farley","year":"2011","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.orcp.2023.05.004_bib3","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archdermatol.2010.92","article-title":"Diet and weight loss as a treatment for psoriasis","volume":"146","author":"Gelfand","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.orcp.2023.05.004_bib4","article-title":"Effects of weight loss on psoriasis: a review of clinical trials","volume":"10","author":"Alotaibi","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.orcp.2023.05.004_bib5","unstructured":"World Health Organization. Regional office for the western Pacific. The Asia\u2013Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia; 2000."},{"key":"10.1016\/j.orcp.2023.05.004_bib6","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00403-015-1593-8","article-title":"Drug safety of systemic treatments for psoriasis: results from the German Psoriasis Registry PsoBest","volume":"307","author":"Reich","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.orcp.2023.05.004_bib7","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","article-title":"Disease concomitance in psoriasis","volume":"32","author":"Henseler","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.orcp.2023.05.004_bib8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/bjd.14557","article-title":"Primary care\u2013based screening for cardiovascular risk factors in patients with psoriasis","volume":"175","author":"Rutter","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.orcp.2023.05.004_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ad.2012.08.003","article-title":"Obesity and psoriasis: inflammatory nature of obesity, relationship between psoriasis and obesity, and therapeutic implications","volume":"105","author":"Carrascosa","year":"2014","journal-title":"Actas Dermo Sifiliogr"},{"key":"10.1016\/j.orcp.2023.05.004_bib10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1159\/000455840","article-title":"Psoriasis and obesity","volume":"232","author":"Jensen","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.orcp.2023.05.004_bib11","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaad.2012.08.015","article-title":"Psoriasis and metabolic syndrome: a systematic review and meta\u2013analysis of observational studies","volume":"68","author":"Armstrong","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.orcp.2023.05.004_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/bjd.16885","article-title":"Metabolic syndrome and risk of incident psoriasis: prospective data from the HUNT Study, Norway","volume":"180","author":"Snekvik","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.orcp.2023.05.004_bib13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2133.2008.08655.x","article-title":"Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation","volume":"159","author":"Johnston","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.orcp.2023.05.004_bib14","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2340\/00015555-2530","article-title":"Overweight and weight gain predict psoriasis development in a population-based cohort","volume":"97","author":"Danielsen","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.orcp.2023.05.004_bib15","first-page":"273","article-title":"Effects of treatment for psoriasis on circulating levels of leptin, adiponectin and resistin: a systematic review and meta-analysis","volume":"179","author":"Kyriakou","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.orcp.2023.05.004_bib16","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/ced.12171","article-title":"Leptin levels in patients with psoriasis: a meta-analysis","volume":"38","author":"Zhu","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.orcp.2023.05.004_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaad.2019.07.103","article-title":"Change in body weight and body mass index in psoriasis patients receiving biologics: a systematic review and network meta-analysis","volume":"82","author":"Wu","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.orcp.2023.05.004_bib18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s12026-013-8410-2","article-title":"Autoantibody induction and adipokine levels in patients with psoriasis treated with infliximab","volume":"56","author":"Lora","year":"2013","journal-title":"Immunol Res"},{"key":"10.1016\/j.orcp.2023.05.004_bib19","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/bjd.12118","article-title":"Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab","volume":"168","author":"Gisondi","year":"2013","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.orcp.2023.05.004_bib20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.5021\/ad.2017.29.6.761","article-title":"Prevalence of Psoriasis in Korea: a population-based epidemiological study using the Korean National Health Insurance Database","volume":"29","author":"Lee","year":"2017","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.orcp.2023.05.004_bib21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2340\/00015555-2877","article-title":"Epidemiology and medication trends in patients with psoriasis: a nationwide population\u2013based cohort study from Korea","volume":"98","author":"Han","year":"2018","journal-title":"Acta Derm Venereol"}],"container-title":["Obesity Research & Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871403X2300042X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871403X2300042X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:30:07Z","timestamp":1761730207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871403X2300042X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1871403X2300042X"],"URL":"https:\/\/doi.org\/10.1016\/j.orcp.2023.05.004","relation":{},"ISSN":["1871-403X"],"issn-type":[{"value":"1871-403X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of biologic agents on body weight and obesity-related disorders in patients with psoriasis: A nationwide population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Obesity Research & Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.orcp.2023.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Asia Oceania Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}